These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 14566462

  • 1. [Minimal Change Glomerulonephritis].
    Stracke S, Helmchen U, Aymanns C, Kadlec N, Lindemann B, Hüttner S, Keller F.
    Internist (Berl); 2003 Sep; 44(9):1090-7. PubMed ID: 14566462
    [Abstract] [Full Text] [Related]

  • 2. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Tang S, Tang AW, Tam MK, Ho YW.
    Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F, Liebl R, Riegger GA, Krämer BK.
    Nephrol Dial Transplant; 1997 Nov; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract] [Full Text] [Related]

  • 5. The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts.
    Shigidi MM.
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):10-7. PubMed ID: 21196608
    [Abstract] [Full Text] [Related]

  • 6. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R, Kumar D A P, Nada R, Jha V, Gupta KL, Kohli HS.
    Nephrology (Carlton); 2015 May; 20(5):384-5. PubMed ID: 25872662
    [No Abstract] [Full Text] [Related]

  • 7. A case of early-stage diabetic nephropathy complicated by minimal change nephrotic syndrome treated with cyclosporin A.
    Matsuda M, Hayashi Y, Shikata K, Makino H, Shikata Y, Sugimoto H, Akiyama K, Kushiro M, Ota Z.
    Nephron; 1997 May; 75(4):490-1. PubMed ID: 9127341
    [No Abstract] [Full Text] [Related]

  • 8. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A, Sabry S, Emil E, El-Refaey M.
    J Nephrol; 2012 May; 25(5):732-7. PubMed ID: 22101675
    [Abstract] [Full Text] [Related]

  • 9. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [Abstract] [Full Text] [Related]

  • 10. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.
    Oh J, Kemper MJ.
    Minerva Pediatr; 2012 Apr; 64(2):197-204. PubMed ID: 22495193
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
    Xu D, Gao X, Bian R, Mei C, Xu C.
    Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
    [Abstract] [Full Text] [Related]

  • 12. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A, Lippman HR, Feldman GM.
    Am J Nephrol; 2002 May; 22(5-6):569-72. PubMed ID: 12381961
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J.
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [Abstract] [Full Text] [Related]

  • 15. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K, Ito H, Anzai M, Matsumura C, Kurayama H.
    J Nephrol; 2013 May; 26(2):306-14. PubMed ID: 22641570
    [Abstract] [Full Text] [Related]

  • 17. The many faces of minimal change nephrotic syndrome: an overview and case study.
    Richardson MA.
    Nephrol Nurs J; 2012 May; 39(5):365-74; quiz 375. PubMed ID: 23094339
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy.
    Kano K, Nishikura K, Hoshi M, Yamada Y, Arisaka O.
    Clin Nephrol; 2001 May; 55(5):424-5. PubMed ID: 11393392
    [No Abstract] [Full Text] [Related]

  • 19. [A case of nephrotic syndrome associated with myasthenia gravis and malignant thymoma].
    Tomida C, Yamagata K, Ishizu T, Nakajima M, Doi M, Kobayashi M, Koyama A.
    Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):77-82. PubMed ID: 10361423
    [Abstract] [Full Text] [Related]

  • 20. [Use of Cyclosporine A and new immunosuppressive drugs in the therapy of glomerulonephritis].
    Dudzik B, Kaczmarczyk I, Radziszewski A, Sułowicz W.
    Przegl Lek; 2001 Apr; 58(7-8):798-804. PubMed ID: 11769390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.